0000874710 false 0000874710 2023-02-02 2023-02-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)
February 2, 2023

 

ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

 

Delaware 0-19266 25-1370721
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices)		 63110
(Zip Code)

 

Registrant’s telephone number, including area code
(314) 771-2400 
 
Not applicable 
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging Growth Company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbol Name of Each Exchange on Which
Registered
Common Stock, $.01 AHPI The NASDAQ Stock Market, LLC

 

 

 

 

 

 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

(b)          On February 2, 2023, the Company’s President and Chief Executive Officer, Joe Ondrus tendered to the Company his intent to resign, effective February 21, 2023. The Company has not yet appointed a successor.

 

Also, on February 2, 2023, the Company’s Vice President - Operations, Kevin Kroupa tendered to the Company his intent to resign, effective February 21, 2023. The Company does not currently plan to appoint a successor to Mr. Kroupa.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ALLIED HEALTHCARE PRODUCTS, INC.
   
   
  By:
Date: February 8, 2023   /s/ Daniel C. Dunn
    Daniel C. Dunn
    Chief Financial Officer

 

 

 

Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Allied Healthcare Products Charts.
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Allied Healthcare Products Charts.